Category Archives: Myocardial Infarction

This article was originally published here Clin Cardiol. 2020 Aug 11. doi: 10.1002/clc.23431 Continue reading →

Background:Acute myocardial infarction complicated by cardiogenic shock (AMICS) occurs in up to 10% of acute myocardial infarction admissions and is associated with high mortality, frequent adverse outcomes, prolonged hospitalizations, extensive medical resource utilization, and major cost. Using hospital cost data for Medicare Fee-for-Service (FFS) patients with AMICS, we sought to evaluate in hospital and 45-day outcomes and cost, comparing patients treated with percutaneous ventricular assist device (pVAD) versus extracorporeal membrane oxygenation (ECMO) Continue reading →

Objective:The aim of our study was to identify the main risk factors for the occurrence of early complications of acute myocardial infarction after cardio-interventional treatment and to evaluate prognostic risk indicators. Patients and methods:Materials and methods: Risk factors of myocardial infarction were determined by copying the case history data and calculating on their basis of the odds ratio and 95% confidence interval Continue reading →

The Myocardial Infarction Drugs Industry market research added by Market Study Report, LLC, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors Continue reading →

Latest Research Report: Myocardial Infarction Treatment industry Myocardial Infarction Treatment Market report is to provide accurate and strategic analysis of the Profile Projectors industry. The report closely examines each segment and its sub-segment futures before looking at the 360-degree view of the market mentioned above. Market forecasts will provide deep insight into industry parameters by accessing growth, consumption, upcoming market trends and various price fluctuations. Continue reading →

Stanly County EMS has received the American Heart Associations Mission: Lifeline EMS Silver Plus Award for implementing quality improvement measures for the treatment of patients who experience severe heart attacks. Every year, more than 250,000 people experience an ST elevation myocardial infarction (STEMI), the deadliest type of heart attack caused by a blockage of blood flow to the heart that requires timely treatment, according to EMS Continue reading →

Accelerating Market Dynamics of Myocardial Infarction (MI) Therapeutics Market: Market Overview Increased adoption of novel antithrombotics Novel antithrombotics such as NOACs and antiplatelet drugs (BRILINTA and Effient) possess the potential to expand the scope of the treatment for MI. Continue reading →

Los Angeles, United State, The report comes out as an intelligent and thorough assessment tool as well as a great resource that will help you to secure a position of strength in the global Myocardial Infarction Therapeutics market. It includes Porters Five Forces and PESTLE analysis to equip your business with critical information and comparative data about the Global Myocardial Infarction Therapeutics Market. Continue reading →

Response Biomedical Scope of the Troponin Market Report:The classification of Troponin includes Troponin I (TnI), Troponin T (TnT), the sales of Troponin I (TnI) are 181 million units, with its market share 80.6%. In addition, the sales market share of Troponin T (TnT) is 19.4% in 2020.North America region is the largest supplier of Troponin, with a production market share nearly 47.2% in 2020. Europe is the second largest supplier of Troponin, enjoying revenue market share nearly 36.2% in 2020.North America is the largest sales place, with market share nearly 41.5% in 2020 Continue reading →

Clinic The study analyses the following key business aspects: Analysis on Strategies of Leading Players: Market players can use this analysis to gain competitive advantage over their competitors in the Myocardial Infarction Drug market. Study on Key Market Trends: This section of the report offers a deeper analysis of the latest and future trends of the Myocardial Infarction Drug market. Market Forecasts:Buyers of the report will have access to accurate and validated estimates of the total market size in terms of value and volume. Continue reading →